Skip to main content

Market Overview

Mid-Afternoon Market Update: Dow Surges 250 Points; Delphi Technologies Shares Gain On Acquisition News

Share:

Toward the end of trading Tuesday, the Dow traded up 0.88% to 28,786 while the NASDAQ rose 1.55% to 9,280.64. The S&P also rose, gaining 1.23% to 3,283.46.

Leading and Lagging Sectors

Information technology shares climbed 2% on Tuesday. Meanwhile, top gainers in the sector included Telaria, Inc. (NYSE: TLRA), up 8%, and SeaChange International, Inc. (NASDAQ: SEAC), up 9%.

In trading on Tuesday, consumer staples shares rose by just 0.3%.

Top Headline

Pfizer Inc. (NYSE: PFE) reported weaker-than-expected results for its fourth quarter.

Pfizer reported quarterly earnings of $0.55 per share, which missed the analyst consensus estimate of 57 cents. The company reported quarterly sales of $12.7 billion, which beat the analyst consensus estimate of $12.61 billion.

Pfizer sees fiscal year 2020 adjusted EPS $2.82-$2.92 versus the $2.90 estimate and sales $48.5 billion-$50.5 billion versus the $49.52 billion estimate.

Equities Trading UP

Armata Pharmaceuticals, Inc. (NYSE: ARMP) shares shot up 88% to $5.25. Armata Pharmaceuticals and Innoviva reported a $25 million strategic investment to support advancement of Armata's bacteriophage development programs.

Shares of Delphi Technologies PLC (NYSE: DLPH) got a boost, shooting up 61% to $15.77 after the company announced it will be acquired by BorgWarner for $3.3 billion in an all-stock transaction.

Acceleron Pharma Inc. (NASDAQ: XLRN) shares were also up, gaining 42% to $75.12 following a data readout. Acceleron said a Phase 2 study dubbed PULSAR that evaluated its sotatercept in patients with pulmonary arterial hypertension, or PAH, met its primary and key secondary endpoints. The experimental drug showed a statistically significant reduction in pulmonary vascular resistance – the primary endpoint - at week 24 versus placebo. The study also achieved the key secondary endpoint of significant improvements in six-minute walk distance, and other secondary endpoints, including amino-terminal brain natriuretic propeptide, and WHO functional class. It was also found to be generally well tolerated.

Equities Trading DOWN

NanoViricides, Inc. (NYSE: NNVC) shares tumbled 44% to $8.82 after surging 86.98% on Monday.

Shares of TESSCO Technologies Incorporated (NASDAQ: TESS) were down 25% to $9.05 after the company reported downbeat Q3 results.

Allied Healthcare Products, Inc. (NASDAQ: AHPI) was down, falling 32% to $2.94 after surging 50% on Monday.

Commodities

In commodity news, oil traded up 0.6% to $53.45, while gold traded down 0.6% to $1,567.40.

Silver traded down 3.4% Tuesday to $17.45, while copper fell 0.5% to $2.583.

Euro zone

European shares closed higher today. The eurozone’s STOXX 600 gained 0.84%, the Spanish Ibex Index rose 1.26%, while Italy’s FTSE MIB Index rose 2.61% Meanwhile, the German DAX gained 0.90%, and the French CAC 40 rose 1.07% while UK shares rose 0.93%.

Economics

The Federal Open Market Committee begins its two-day policy meeting.

U.S. durable goods orders rose 2.4% in December, versus a revised 3.1% decline in the previous month.

The Johnson Redbook Retail Sales Index rose 0.1% during the first three weeks of January versus December.

The S&P Corelogic Case-Shiller home price index climbed 2.6% year-over-year in November, compared to a 2.2% rise in the previous month.

The Conference Board consumer confidence index rose to 131.6 in January, versus a revised reading of 128.2 in the previous month.

 

Related Articles (AHPI + ARMP)

View Comments and Join the Discussion!

Posted-In: Mid-Afternoon Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com